Ideagen PLC PDMR Shareholding and Exercise of Options (3934E)
05 November 2020 - 9:46PM
UK Regulatory
TIDMIDEA
RNS Number : 3934E
Ideagen PLC
05 November 2020
5 November 2020
Ideagen PLC
("Ideagen," the "Company" or the "Group")
PDMR dealing, exercise of options and total voting rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
Elizabeth Hewitt, the wife of Alex Hewitt, Chief Legal Officer, has
sold 16,000 ordinary shares of 1 penny each in the capital of the
Company ("Ordinary Shares") at a price of 223 pence on 3 November
2020. Following the sale of shares, Mr Hewitt has a beneficiary
interest in 116,095 shares, representing 0.05% of the issued share
capital of the Company.
Additionally, the Company received notification, from an
employee, for the exercise of options over 75,000 ordinary shares
("New Ordinary Shares") in the Company at an exercise price of 35
pence per New Ordinary Share.
Application has been made to the London Stock Exchange for the
75,000 New Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 11 November
2020.
After Admission, the total number of Ordinary Shares in issue
will be 226,918,008 and the total number of voting rights will
therefore be 226,918,008. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
Ideagen plc 01629 699 100
David Hornsby, Executive Chairman
Ben Dorks, Chief Executive Officer
Emma Hayes, Chief Financial Officer
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson/Kate
Washington (Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides software and services to organisations
operating within highly regulated industries such as aviation,
banking and finance and life science, with its main operational
premises spread throughout the UK, EU, US, Middle East and SE
Asia.
With an excellent portfolio of software products including
Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its
clients reduce costs, improve operational efficiency, strengthen
compliance and oversight and anticipate and manage every detail of
risk.
Currently, more than 5,500 organisations use Ideagen's products
including eight of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 180 hospitals across
the UK and US
amongst its client base.For further information please visit www.ideagen.com .
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Alex Hewitt
------------------------------------------------ ---------------------------------------------
2. Reason for the Notification
-----------------------------------------------------------------------------------------------
a) Position/status Chief Legal Officer and PDMR
------------------------------------------------ ---------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------ ---------------------------------------------
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Ideagen plc
------------------------------------------------ ---------------------------------------------
b) LEI 213800KS1MLITOVNYC85
------------------------------------------------ ---------------------------------------------
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the Financial Ordinary Shares of 1p each
instrument, type of instrument
------------------------------------------------ ---------------------------------------------
Identification code GB00B0CM0C50
------------------------------------------------ ---------------------------------------------
b) Nature of the transaction Sale of shares
------------------------------------------------ ---------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
223 pence 16,000
----------
------------------------------------------------ ---------------------------------------------
d) Aggregated information: Sale of 16,000 ordinary shares
-- Aggregated volume at 223 pence per share
-- Price
------------------------------------------------ ---------------------------------------------
e) Date of the transaction 3 November 2020
------------------------------------------------ ---------------------------------------------
f) Place of the transaction AIM
------------------------------------------------ ---------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHKKPBQKBDDPDK
(END) Dow Jones Newswires
November 05, 2020 05:46 ET (10:46 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024